Voloridge Investment Management’s Immunomedics Inc IMMU Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-567,996
| Closed | -$48.3M | – | 1681 |
|
|
2020
Q3 | $48.3M | Buy |
567,996
+24,708
| +5% | +$1.25M | 0.4% | 50 |
|
|
2020
Q2 | $19.3M | Buy |
+543,288
| New | +$15.9M | 0.22% | 91 |
|
|
2020
Q1 | – | Sell |
-109,597
| Closed | -$2.32M | – | 1533 |
|
|
2019
Q4 | $2.32M | Buy |
+109,597
| New | +$1.93M | 0.05% | 456 |
|
|
2019
Q3 | – | Sell |
-159,677
| Closed | -$2.21M | – | 1275 |
|
|
2019
Q2 | $2.21M | Buy |
+159,677
| New | +$2.4M | 0.06% | 307 |
|
|
2018
Q4 | – | Sell |
-115,766
| Closed | -$2.41M | – | 518 |
|
|
2018
Q3 | $2.41M | Sell |
115,766
-14,729
| -11% | -$349K | 0.05% | 192 |
|
|
2018
Q2 | $3.09M | Buy |
+130,495
| New | +$2.62M | 0.08% | 226 |
|
|
2017
Q4 | – | Sell |
-304,184
| Closed | -$4.25M | – | 650 |
|
|
2017
Q3 | $4.25M | Buy |
304,184
+230,787
| +314% | +$2.3M | 0.1% | 205 |
|
|
2017
Q2 | $648K | Sell |
73,397
-128,473
| -64% | -$902K | 0.02% | 344 |
|
|
2017
Q1 | $1.31M | Buy |
+201,870
| New | +$1.02M | 0.03% | 358 |
|
Voloridge Investment Management's IMMU Position: Q4 2020 in Review
Voloridge Investment Management sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 567,996 shares — an estimated $48.3M sold.
Voloridge Investment Management first reported a position in IMMU in Q1 2017 and held it in 9 quarters. The position peaked at $48.3M in Q3 2020. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.
- Voloridge Investment Management reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
- Voloridge Investment Management sold 567,996 Immunomedics Inc shares in Q4 2020, an estimated $48.3M.
- Voloridge Investment Management first reported a position in Immunomedics Inc in Q1 2017 and held it in 9 quarters.
- Voloridge Investment Management's Immunomedics Inc position peaked at $48.3M in Q3 2020.
- 0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.
Based on Voloridge Investment Management's 13F filing for Q4 2020, filed 16 Feb 2021.